Global Molecular Modelling Market Research Report – Forecast to 2023


The global molecular modelling market was valued at USD 377 million in 2017 and is expected to register a CAGR of 15.46% from 2018 to 2023.

SKU: 180412 Category: Tag:


Molecular Modelling Market

Molecular modelling, as the name itself suggests, is concerned with molecules, their calculations, and predictions with respect to the research field. Molecular modelling can also be stated as an analysis of the ways to mimic the behaviour of molecules and molecular systems.

Currently, molecular modelling is invariably associated with computer modelling, where computational biology techniques are involved. These molecular modelling techniques are widely used in the chemical and pharmaceutical industry. Molecular modelling plays a crucial role in drug discovery.

Molecular modelling has developed as a valuable and essential tool in various healthcare applications such as drug designing, drug development, and drug discovery processes. Molecular modelling describes the generation, manipulation, or representation of three-dimensional structures of molecules and associated physicochemical properties.

The growth of the global molecular modelling market is attributed to the increasing investments in research and development by pharmaceutical and biotechnology companies, technological advancements in drug design, and increasing prevalence of various chronic diseases which increases the demand for drug development. However, the high cost of research and development is restraining the growth of the market.

Molecular modelling is a powerful technique in drug designing. The development of new drugs with possible therapeutic applications is one of the most difficult processes in the pharmaceutical industry. In drug designing and discovery, both computational and experimental techniques play important roles and represent complementary approaches.

However, molecular modelling is safe and easy to use tool, which helps in investigating, interpreting, explaining, and identifying molecular properties using three-dimensional structures. During drug designing, molecular modelling tries to predict the structure of the intermolecular complex formed between two or more constituent molecules.

Molecular Diagnostics Market-Analysis and Forecast,2021-2031

The global molecular modelling market is segmented based on the basis of product, application, end-user, and region.
Based on product, the market is further segmented into software and services.
Based on application, the market is segmented into drug development, drug discovery, and others.
Based on end-user, the market is segmented into pharmaceutical and biotechnological companies, research centres and academic institutions, and others.

The global molecular modelling market was valued at USD 377 million in 2017 and is expected to register a CAGR of 15.46% from 2018 to 2023.

Key Players
Simulations Plus, Inc., Chemical Computing Group, Certara, L.P, OpenEye Scientific Software, Dassault Systèmes, Cambridge Crystallographic Data Centre, Cresset, Acellera Ltd., Schrödinger, LLC, Optibrium, BioSolve-IT, and others

Study objectives

• To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global molecular modelling market
• To provide insights into factors influencing and affecting the market growth
• To provide historical and forecast revenue of market segments and sub-segments with respect to countries
• To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influence the global molecular modelling market
• To provide a detailed analysis of the value chain and supply chain of the global molecular modelling market

Target Audience
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Academic Institutes and Universities
• Potential Investors

Key Findings
• The global molecular modelling market is expected to reach USD 893.1 million by 2023 at a CAGR of 15.46% from 2018 to 2023
• Based on product, software accounted for the largest market share of 63.1% in the year 2017 and was valued at USD 237.79 million in the same year
• Based on application, drug discovery accounted for the largest market share of 58.0% in 2017
• The Americas holds the largest share of the global molecular modelling market which is expected to reach USD 470.6 million by 2023
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 14.65% from 2018 to 2023

Regional Analysis
• Americas
o North America
 US
 Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Additional information


Geography Covered

Date Published



Table of Contents


1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of the Study
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing prevalence of various chronic diseases leading to drug development
4.2.2 Technological advancements in drug design
4.2.3 Increasing investments in research & development by pharmaceutical and biotechnology companies
4.3 Restraints
4.3.1 Higher cost of molecular modelling software
4.3.2 Lack of skilled healthcare IT professionals in low and middle-income economies
4.4 Opportunities
4.4.1 Introduction of molecular modelling software and services in developing economies
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Threat of New Entrants
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Inputs
5.2.2 Software Development Processes
5.2.3 Output
5.2.4 Marketing and Distribution
5.2.5 Post-Selling Services
5.3 Investment Opportunity Analysis
5.4 Price Analysis
6 Global Molecular Modelling Market by Product
6.1 Introduction
6.2 Software
6.3 Services
7 Global Molecular Modelling Market by Application
7.1 Introduction
7.2 Drug Development
7.3 Drug Discovery
7.4 Others
8 Global Molecular Modelling Market by End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.3 Research & Academic Centers
8.4 Others
9 Global Molecular Modelling Market by Region
9.1 Introduction
9.2 Americas
9.2.1 North America US Canada
9.2.2 South America
9.3 Europe
9.3.1 Western Europe Germany France U.K Italy Spain Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
10 Competitive Landscape
10.1 Introduction
10.2 Company Ranking
11 Company Profiles
11.1 Simulations Plus, Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offering
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.1.6 Key Strategy
11.2 Cambridge Crystallographic Data Centre
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offering
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.2.6 Key Strategy
11.3 Optibrium
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offering
11.3.4 Key Developments
11.3.5 SWOT Analysis
11.3.6 Key Strategy
11.4 Cresset
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offering
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.4.6 Key Strategy
11.5 BioSolveIT GmbH
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offering
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.5.6 Key Strategy
11.6 OpenEye Scientific Software
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offering
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.6.6 Key Strategy
11.7 Chemical Computing Group
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offering
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.7.6 Key Strategy
11.8 Acellera Ltd.
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offering
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.8.6 Key Strategy
11.9 Dassault Systèmes
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offering
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.9.6 Key Strategy
11.1 Schrödinger, LLC
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offering
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.10.6 Key Strategy
11.11 Certara, L.P
11.11.1 Company Overview
11.11.2 Financial Overview
11.11.3 Products Offering
11.11.4 Key Developments
11.11.5 SWOT Analysis
11.11.6 Key Strategy
12 Appendix
12.1 Discussion Blue Print